`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`U.S. ENDOSCOPY GROUP, INC. (PETITIONER)
`
`Petitioner
`
`V.
`
`CDX DIAGNOSTICS INC. and
`
`SHARED MEDICAL RESOURCES LLC
`
`PATENT OWNERS
`
`CASE IPR2014-00642
`
`Patent 6,258,044
`
`CDX DIAGNOSTICS INC.’S AND SHARED MEDICAL RESOURCES LLC’S
`
`MANDATORY NOTICES
`
`UNDER 37 CPR. §42.8
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`US Patent and Trademark Office
`
`PO. Box 1450
`
`Alexandria, VA 22313—1450
`
`
`
`Case [PR2014-00642
`
`Patent 6,258,044
`
`Patent owners, CDX Diagnostics, Inc. and Shared Medical Resources LLC,
`
`hereby file mandatory notices pursuant to 37 OF .R. § 42.8(a)(2). These notices
`
`are being timely filed within 21 days of service of the petition, which was on April
`
`15,2014.
`
`A. Real Party—in-Interest (37 C.F.R. § 423(3))
`
`CDX Diagnostics Inc. and Shared Medical Resources, LLC are joint and c0-
`
`equal owners of the entire interest in U.S. Patent No. 6,25 8,044 (the “ ‘044
`
`patent”), and thus are real-part1es—in—interest.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2))
`
`The following judicial matters may be affected by a decision in this proceeding:
`
`CDx Diagnostics Inc. cf (11. v. U.S. Endoscopy Group, Inc., United States
`
`District Court for the Southern District of New York, Case No. l3-cv-5669 NSR
`
`(“CDX Diagnostics, Inc. et al. V. U.S. Endoscopy Group, ”).
`
`CDx Diagnostics Inc. et a]. v. Histologics LLC, United States District Court for
`
`the Central District of Caiifornia, Case No. l3—cv-07909 (“CDX Diagnostics,
`
`Inc.V. Histologics, LLC”).
`
`
`
`Case IPR2014-00642
`
`Patent 6,258,044
`
`C. Lead and Back-up Counsel ((37 C.F.R. § 42.8(b)(3))
`
`Patent Owners designate the following counsel:
`
`Lead Counsel: PeterL. Berger (Reg. No. 24,570) (1: 212-486-7272
`
`Back—up Counsel: Tuvia Rotberg (Reg. No. 58,167) d: 212-486-7272
`
`Address:
`
`Levisohn Berger LLP
`11 Broadway, Suite 615
`New York, New York 10004
`212-486—7272 (telephone)
`212—486-0323 (facsimile)
`pbergergQIIblcom
`trotberg@,llbl.com
`
`D. Service Information (37 C.F.R. § 42.8(b)(4))
`
`Please direct all correspondence regarding this proceeding to the lead counsel at
`
`the address listed above. Patent Owners also consent to electronic service by email
`
`to pherger@llbl.com, trotberg@,11bl.com and wru
`
`iera
`
`llbl.com.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 02-2105, (Customer ID 04617)
`
`Dated: April 30, 2014
`
`Respectfully Submitted,
`
`/s/ Peter L. Berger
`Peter L. Berger (Reg. No. 24,570)
`Attorney for Patent Owner
`CDX Diagnostics, Inc.
`
`LEVISOHN BERGER LLP
`
`11 Broadway, Suite 615
`New York, New York 10004
`212—486-7272 (Telephone)
`212-486-0323 (Facsimile)
`
`
`
`Case IPR2014—00642
`
`Patent 6,258,044
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing CDX Diagnostics Inc.’s
`
`MANDATORY NOTICES UNDER 37 C.F.R. 42.8 § 42.10(b) was served on
`
`April 30, 2014 via Federal Express to the following:
`
`Todd R. Tucker
`
`Mark W. McDougall
`CALFEE, HALTER, & GRISWOLD LLP
`The Calfee Building
`1405 East Sixth Street
`
`Cleveland, OH 44114
`
`Respectfully Submitted,
`
`/s/ Peter L. Berger
`Peter L. Berger (Reg. No. 24,570)
`Attorney for Patent Owners
`CDX Diagnostics Inc. and
`Shared Medical Resources, LLC
`
`